Nindya Zanaria Lubis, MD
Bandung Eye Center Hospital & Clinic
Bandung, Indonesia
I am sincerely grateful to the Asia Cornea Society (ACS) and Santen for awarding me the ACS-Santen Asia Educational Observership Grant 2026, which provided me with the invaluable opportunity to undertake a one-month Cornea Clinical Observership Program at the Department of Ophthalmology, Graduate School of Medicine, The University of Osaka, Japan.
Under the leadership of Professor Kohji Nishida, the department is internationally recognized for its contributions to corneal transplantation, ocular surface reconstruction, and regenerative medicine. Throughout my observership, I had the privilege of learning from Professor Shizuka Koh, Professor Takeshi Soma, Professor Yoshinori Oie, Professor So Goto, Dr. Rei Kamuro, and Dr. Sayo Maeno, who generously shared their clinical knowledge, surgical expertise, and insights into corneal and ocular surface diseases.
One of the major highlights was the extensive exposure to advanced corneal transplantation procedures. I observed numerous cases of penetrating keratoplasty (PKP), non-Descemet stripping automated endothelial keratoplasty (n-DSAEK), Descemet membrane endothelial keratoplasty (DMEK), and combined endothelial keratoplasty and cataract surgery, including DSEK triple procedures. These experiences provided valuable insights into surgical techniques, intraoperative decision-making, and the management of complex corneal conditions. Discussions regarding Japan’s eye-banking system also broadened my understanding of donor tissue availability, preparation, and its essential role in corneal transplantation.
A particularly memorable experience was witnessing the first Vyznova cultured human corneal endothelial cell injection therapies performed at The University of Osaka Hospital. This innovative treatment represents a significant advancement in the management of corneal endothelial dysfunction, offering new possibilities beyond conventional corneal transplantation. We were also kindly given the opportunity to observe the patients’ early postoperative progress over the following two weeks. The initial outcomes were very promising, and witnessing this clinical milestone firsthand was undoubtedly one of the most remarkable experiences of my observership.
Beyond corneal transplantation, I was exposed to various anterior segment procedures, including phototherapeutic keratectomy (PTK) for corneal abnormalities such as Avellino corneal dystrophy, as well as cataract and refractive surgeries. Discussions surrounding premium intraocular lens selection, patient expectations, and shared decision-making were particularly insightful, emphasizing the importance of individualized treatment planning.
Another valuable aspect was learning about surgical innovations and technologies, including the NS Endo-Inserter, developed by Professor Kohji Nishida and Professor Takeshi Soma to facilitate endothelial graft insertion during corneal transplantation. We also attended a demonstration of the Leica Proveo 8 surgical microscope, providing further insights into technological advancements in ophthalmic surgery.
One of the most fascinating experiences was visiting the department’s research laboratory, where we had a closer look at induced pluripotent stem cell (iPSC)-derived corneal epithelial cell sheets and learned about their potential applications in ocular surface reconstruction. We were also introduced to ongoing research involving iPSC-derived cells for other ocular tissues, including the lacrimal gland and retina. This experience highlighted the remarkable efforts being made to translate laboratory discoveries into clinical applications and offered a glimpse into the future of regenerative ophthalmology.
The outpatient clinics were equally valuable learning environments. As one of Japan’s leading tertiary referral hospitals, The University of Osaka Hospital manages numerous complex corneal and ocular surface diseases, including advanced keratoconus and challenging postoperative cases. Each clinical session provided opportunities to observe comprehensive patient assessments and engage in discussions regarding differential diagnoses and management strategies. I particularly appreciated the openness of the supervising physicians, who consistently welcomed our questions and encouraged thoughtful discussions, broadening my clinical perspective.
Towards the end of the observership, I also had the opportunity to attend the 80th Annual Congress of Japan Clinical Ophthalmology in Kyoto. Participating in this scientific meeting was a wonderful conclusion to the program, allowing me to further broaden my knowledge and gain exposure to contemporary ophthalmic research and developments in Japan.
Beyond the remarkable clinical and academic experiences, what made this observership especially meaningful was the warmth and generosity of the people who welcomed us.
I would like to express my deepest appreciation to Professor Shizuka Koh, who thoughtfully arranged and coordinated our observership schedule, ensuring comprehensive exposure to the department’s clinical, surgical, and research activities. Her dedication, kindness, and continuous support made our learning experience exceptionally rewarding.
I am also sincerely grateful to Professor Kohji Nishida for the opportunity to learn at his department, and to Professor Takeshi Soma, Professor Yoshinori Oie, Professor So Goto, Professor Masahiro Kitao, Dr. Rei Kamuro, and Dr. Sayo Maeno for their generous guidance and willingness to share their expertise. My appreciation also extends to all the residents, nurses, researchers, and administrative staff whose kindness and assistance made us feel welcome and supported throughout our stay.
On a personal note, I am particularly thankful to Professor Koh for arranging for me to undertake this observership alongside Dr. Hanifah Rahmani Nursanti, Sp.M, a fellow ACS-Santen Grant awardee from Cipto Mangunkusumo Hospital-Kirana, Jakarta, Indonesia. Sharing this experience with a colleague from my home country made our transition and adaptation considerably easier. Our discussions, shared learning experiences, and mutual support enriched the entire program, and I am delighted that this observership also brought us a wonderful new friendship.
This observership has been a meaningful milestone in my professional journey. Beyond expanding my knowledge of advanced corneal transplantation, ocular surface diseases, and regenerative medicine, it has encouraged me to approach clinical challenges with a broader perspective and a deeper appreciation for continuous learning, innovation, and collaboration.
I look forward to incorporating the knowledge and perspectives gained into my clinical practice at Bandung Eye Center Hospital & Clinic and sharing them with my colleagues and younger doctors, contributing to the continued improvement of corneal and ocular surface care in Indonesia.
Finally, I extend my heartfelt gratitude once again to the Asia Cornea Society and Santen for making this opportunity possible, and to the entire Department of Ophthalmology at The University of Osaka for their hospitality, mentorship, and dedication to education. I wholeheartedly recommend this grant to fellow ophthalmologists seeking to broaden their clinical perspectives and experience the latest developments in corneal and ocular surface medicine.
The knowledge, inspiration, friendships, and memories gained during this observership will undoubtedly remain with me throughout my professional journey.